Fever machine: could controlled heat be a new therapy?
NCT ID NCT07564440
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests the safety of a device called the Abreu BTT 700, which gently raises a person's body temperature to a fever-like level. Twenty healthy adults aged 18 to 65 will receive one session of this controlled hyperthermia. Researchers will monitor for side effects and changes in vital signs and blood tests over three days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- controlled induced hyperthermia (device-based)
- What this could lead to
- If safe, this could pave the way for using controlled fever-range temperature as a therapy for various conditions.
- What could go wrong
- This is a very small, early safety study with only 20 healthy volunteers. It is not designed to test effectiveness, and the approach may not prove safe or useful for treating diseases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY STUDY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BTT Medical Institute LLC
Aventura, Florida, 33160, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.